Quimi Daphne 4
4 · AMICUS THERAPEUTICS, INC. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
Quimi Daphne
Corporate Controller
Transactions
- Sale
Common Stock
2022-09-01$11.29/sh−4,397$49,621→ 335,312 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.99 to $11.57. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.